NEOPHOTONICS CORP
NPTN
NPTN was delisted on the 2nd of August, 2022.
2 hedge funds and large institutions have $5K invested in NEOPHOTONICS CORP in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 154 closing their positions.
99% less funds holding
Funds holding: 156 → 2 (-154)
100% less funds holding in top 10
Funds holding in top 10: 5 → 0 (-5)
100% less capital invested
Capital invested by funds: $741M → $5K (-$741M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 154
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$54.7M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$41.6M |
| 3 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
-$36.9M |
| 4 |
State Street
Boston,
Massachusetts
|
-$36.3M |
| 5 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$33M |
NPTN Hedge Fund Activity: Q3 2022 in Review
2 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in NEOPHOTONICS CORP (NPTN) for Q3 2022, worth a combined $5K — down 100% from $741M a quarter earlier.
Sellers outnumbered buyers: 154 funds closed out of NPTN and 0 opened new positions — a net loss of 154 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was BlackRock, exiting entirely with an estimated $54.7M sold.
- 2 institutional investors held NEOPHOTONICS CORP (NPTN) as of Q3 2022, down from 156 in Q2 2022.
- Funds reported $5K of NEOPHOTONICS CORP stock for Q3 2022, down 100% quarter-over-quarter.
- 0 funds opened new NEOPHOTONICS CORP positions in Q3 2022 and 154 closed out, a net change of -154 holders.
- The largest NEOPHOTONICS CORP seller in Q3 2022 was BlackRock, an estimated $54.7M sold.
Based on aggregated 13F filings for Q3 2022.